digital health IPO

The startup's approach combines a low-cost digital-imaging device for hospitals with a comprehensive medical-imaging software platform. 

CNBC is reporting that AmWell is looking to go public in September. 

The timing and pricing of the Seattle company's IPO are yet to be determined.

While the tech-enabled primary care provider set the initial pricing of its shares at $14 apiece, prices are climbing in the early hours of its IPO.

According to a Wall Street Journal report, the digital chronic disease management company is eyeing a $1B-plus valuation.

Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.

Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.

Dallas, Texas-based video visits company Teladoc has updated its IPO filing, which now discloses that the company plans to raise $119 million in its IPO, if it is priced at the high end of its range.

Jawbone's UP2 device Some 20 percent of investors said they expect Jawbone to go public this year, according to a Rock Health survey of 43 investors.

Jawbone UP3 A pair of (worthwhile but lengthy) features running in Fortune and Forbes this week offered up an in-depth look at 16-year-old health and fitness tracking company Jawbone, makers of the UP line of wearable wristbands.